- Home
- RYTM vs MIR Comparison
RYTM vs MIR Comparison
Compare RYTM & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- MIR
- Stock Information
- Founded
- RYTM 2008
- MIR 2005
- Country
- RYTM United States
- MIR United States
- Employees
- RYTM N/A
- MIR N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- MIR Industrial Machinery/Components
- Sector
- RYTM Health Care
- MIR Technology
- Exchange
- RYTM Nasdaq
- MIR Nasdaq
- Market Cap
- RYTM 3.8B
- MIR 3.7B
- IPO Year
- RYTM 2017
- MIR N/A
- Fundamental
- Price
- RYTM $61.33
- MIR $19.11
- Analyst Decision
- RYTM Strong Buy
- MIR Strong Buy
- Analyst Count
- RYTM 12
- MIR 4
- Target Price
- RYTM $76.75
- MIR $18.75
- AVG Volume (30 Days)
- RYTM 632.6K
- MIR 3.4M
- Earning Date
- RYTM 05-07-2025
- MIR 04-29-2025
- Dividend Yield
- RYTM N/A
- MIR N/A
- EPS Growth
- RYTM N/A
- MIR N/A
- EPS
- RYTM N/A
- MIR N/A
- Revenue
- RYTM $136,863,000.00
- MIR $870,200,000.00
- Revenue This Year
- RYTM $37.88
- MIR $6.26
- Revenue Next Year
- RYTM $72.84
- MIR $7.51
- P/E Ratio
- RYTM N/A
- MIR N/A
- Revenue Growth
- RYTM 48.88
- MIR 7.25
- 52 Week Low
- RYTM $35.35
- MIR $9.11
- 52 Week High
- RYTM $68.58
- MIR $19.70
- Technical
- Relative Strength Index (RSI)
- RYTM 51.78
- MIR 72.19
- Support Level
- RYTM $58.72
- MIR $17.63
- Resistance Level
- RYTM $63.24
- MIR $19.70
- Average True Range (ATR)
- RYTM 2.43
- MIR 0.66
- MACD
- RYTM -0.15
- MIR 0.14
- Stochastic Oscillator
- RYTM 65.51
- MIR 81.80
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.